rs2039531
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001365999.1(SZT2):c.6034+11A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.376 in 1,612,742 control chromosomes in the GnomAD database, including 121,820 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 8608 hom., cov: 33)
Exomes 𝑓: 0.38 ( 113212 hom. )
Consequence
SZT2
NM_001365999.1 intron
NM_001365999.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.166
Publications
10 publications found
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
SZT2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 1-43435340-A-C is Benign according to our data. Variant chr1-43435340-A-C is described in ClinVar as Benign. ClinVar VariationId is 260619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.404 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SZT2 | ENST00000634258.3 | c.6034+11A>C | intron_variant | Intron 42 of 71 | 5 | NM_001365999.1 | ENSP00000489255.1 | |||
| SZT2 | ENST00000562955.2 | c.5863+11A>C | intron_variant | Intron 41 of 70 | 5 | ENSP00000457168.1 | ||||
| SZT2 | ENST00000648058.1 | n.2488+11A>C | intron_variant | Intron 10 of 39 | ||||||
| SZT2 | ENST00000649403.1 | n.784+11A>C | intron_variant | Intron 7 of 36 |
Frequencies
GnomAD3 genomes AF: 0.312 AC: 47397AN: 151930Hom.: 8610 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
47397
AN:
151930
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.325 AC: 81260AN: 249812 AF XY: 0.325 show subpopulations
GnomAD2 exomes
AF:
AC:
81260
AN:
249812
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.383 AC: 558898AN: 1460694Hom.: 113212 Cov.: 36 AF XY: 0.377 AC XY: 273944AN XY: 726630 show subpopulations
GnomAD4 exome
AF:
AC:
558898
AN:
1460694
Hom.:
Cov.:
36
AF XY:
AC XY:
273944
AN XY:
726630
show subpopulations
African (AFR)
AF:
AC:
4628
AN:
33466
American (AMR)
AF:
AC:
14889
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
AC:
11313
AN:
26126
East Asian (EAS)
AF:
AC:
3988
AN:
39684
South Asian (SAS)
AF:
AC:
13590
AN:
86200
European-Finnish (FIN)
AF:
AC:
20825
AN:
53080
Middle Eastern (MID)
AF:
AC:
2271
AN:
5756
European-Non Finnish (NFE)
AF:
AC:
465661
AN:
1111378
Other (OTH)
AF:
AC:
21733
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
17092
34183
51275
68366
85458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13976
27952
41928
55904
69880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.312 AC: 47415AN: 152048Hom.: 8608 Cov.: 33 AF XY: 0.308 AC XY: 22878AN XY: 74290 show subpopulations
GnomAD4 genome
AF:
AC:
47415
AN:
152048
Hom.:
Cov.:
33
AF XY:
AC XY:
22878
AN XY:
74290
show subpopulations
African (AFR)
AF:
AC:
5897
AN:
41474
American (AMR)
AF:
AC:
5823
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1475
AN:
3466
East Asian (EAS)
AF:
AC:
384
AN:
5170
South Asian (SAS)
AF:
AC:
707
AN:
4818
European-Finnish (FIN)
AF:
AC:
4135
AN:
10564
Middle Eastern (MID)
AF:
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
AC:
27703
AN:
67962
Other (OTH)
AF:
AC:
777
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1618
3236
4855
6473
8091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
448
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 18 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.